Principle Investigator: Samir Khleif, MD “D4193C00001; A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)” Sponsor: AstraZeneca...
Researchers and healthcare workers from across the region gathered at GRU on September 18, 2015 for a CME-certified, full-day program, “Tumor Immunology 101: A Navigation Guide for the Growing Field of Cancer Immunotherapy,” organized by GRU Cancer...
Dr. Khleif was recently televised on The Means Report in an interview with WJBF’s Brad Means. In the 30-minute segment, Georgian and former President Jimmy Carter’s melanoma was discussed, as well as GRU Cancer Center’s recently received...